Intellia Therapeutics, Inc. (NTLA Quick QuoteNTLA - Free Report) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, NTLA broke out above the 50-day moving average, suggesting a short-term bullish trend.

One of the three major moving averages, the 50-day simple moving average is commonly used by traders and analysts to determine support or resistance levels for different types of securities. However, the 50-day is considered to be more important since it's the first marker of an up or down trend.

NTLA has rallied 21.5% over the past four weeks, and the company is a Zacks Rank #2 (Buy) at the moment. This combination suggests NTLA could be on the verge of another move higher.

Looking at NTLA's earnings estimate revisions, investors will be even more convinced of the bullish uptrend. There have been 3 higher compared to none lower for the current fiscal year, and the consensus estimate has moved up as well.

Investors may want to watch NTLA for more gains in the near future given the company's key technical level and positive earnings estimate revisions.